Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash.
By THE ASSOCIATED PRESS, NY Times: Business
Sun, 08/25/2013 - 2:46pm
Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash.